The FDA has approved the first lotion formulation of the acne drug tretinoin to help ward off dryness, peeling, and sensitivity that often are associated with topical retinoids.
Marketed under the brand name Altreno, the lotion is indicated for patients aged 9 years or older who have acne vulgaris. Extensive clinical data show that topical retinoid therapy is highly effective in treating acne, but some patients avoid using it because it can irritate skin. The recently approved lotion formula, which contains moisturizing hyaluronic acid and collagen, was less irritating than a similar gel formulation.
Voelker R. Tretinoin in New Lotion Formula. JAMA. 2018;320(13):1309. doi:10.1001/jama.2018.14129
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: